You are viewing a free limited preview of SomaLogic, Inc.
Get Full Access To This Report 
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
SomaLogic, Inc. is a privately-held, venture capital backed biomarker discovery and clinical proteomics company that engages in developing protein signature applications and instrument platforms based on aptamer array technology. It has a strategic collaboration with deCODE Biostructures, Inc. Founded in 1999 by Dr. Larry Gold, SomaLogic, Inc. is headquartered in Boulder, Colorado.
| Company Tags: | PE Backed VC Backed |
| Year Founded: | 1999 |
| Fiscal Year End: | 12/31 |
| City: | Boulder |
| State/Province: | Colorado |
| Country: | United States |
| Phone: | View |
| Website: | www.somalogic.com |
| Brands: | SOMAmers |
| Founders: | Larry Gold |
| Technology > Biotechnology > Artificial Organs & Pacemakers |
| Technology > Biotechnology > Medical Diagnostic Technology |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Export All SomaLogic, Inc. Financials To Excel
$99 Single Company AccessInstant Full Site-Wide Access| Financial Notes: | |
| * | SomaLogic, Inc. fiscal year end: 12/31 |
Export All SomaLogic, Inc. Financials To Excel
$99 Single Company AccessInstant Full Site-Wide Access| Date | Status | Target | Buyer | Deal Type | Price | |
| Details | Aug. 2010 | Completed | View | View | Minority Stake Purchase | View |
Missing a deal? Tell us about it! tips@privco.com
$99 Single Company AccessInstant Full Site-Wide Access| Date | Investor | Round | Investor Type | |
| Nov. 2000 | LODH Private Equity Partners | Other | ||
| Nov. 2000 | NewWest Capital Partners | Other | Private Equity | |
| Nov. 2000 | ProQuest Investments | Other | Venture Capital | |
| Nov. 2000 | SG Gestion | Other | ||
| Nov. 2000 | Skye Investment Advisors | Other | ||
| Details | Total Round Other $23,000,000 | |||
| Dec. 2002 | Mitsui & Co Ltd | C | Corporate | |
| Dec. 2002 | ProQuest Investments | C | Venture Capital | |
| Dec. 2002 | Societe Generale | C | Venture Capital | |
| Details | Total Round C1 $19,502,996 | |||
| Feb. 2003 | Mitsui & Co Ltd | Other | Corporate | |
| Feb. 2003 | LODH Private Equity Partners | Other | ||
| Feb. 2003 | NewWest Capital Partners | Other | Private Equity | |
| Feb. 2003 | ProQuest Investments | Other | Venture Capital | |
| Feb. 2003 | SG Gestion | Other | Private Equity | |
| Feb. 2003 | Skye Investment Advisors | Other | Private Equity | |
| Details | Total Round Other $19,500,000 | |||
| Nov. 2003 | Mitsui & Co Ltd | D | Corporate | |
| Nov. 2003 | ProQuest Investments | D | Venture Capital | |
| Nov. 2003 | Sumitomo Bakelite Co. Ltd. | D | Corporate | |
| Details | Total Round D2 $11,000,000 | |||
| May. 2005 | Quest Diagnostics Incorporated | Other | Venture Capital | |
| Details | Total Round Other $15,000,000 | |||
| Sep. 2007 | View | Venture Round | Venture Capital | |
| Sep. 2007 | View | Venture Round | Corporate | |
| Sep. 2007 | View | Venture Round | Corporate | |
| Details | Total Round Venture Round3 View | |||
| May. 2008 | View | Other | Venture Capital | |
| May. 2008 | View | Other | Venture Capital | |
| May. 2008 | View | Other | ||
| Details | Total Round Other View | |||
| Aug. 2010 | View | Other | Corporate | |
| Details | Total Round Other View | |||
| Nov. 2010 | View | Other | Venture Capital | |
| Details | Total Round Other View | |||
| Total of Funding Shown Above View | ||||
| 1 | Total amount offered was $25,000,000. Total number of investors was 16. - Details → |
| 2 | Total amount offered $12,500,014. - Details → |
| 3 | Total...Read More → |
Full-length notes are available with Single Report Access or PrivCo Premium Subscription. |
Missing a deal? Tell us about it! tips@privco.com
$99 Single Company AccessInstant Full Site-Wide AccessSomaLogic Business Model
SomaLogic, Inc. is a privately-held company that operates as a protein biomarker discovery and clinical diagnostics company. SomaLogic’s two primary offerings include, SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. SomaLogic’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures, drug discovery and development, and clinical diagnostics.
SomaLogic's SOMAmer and SOMAscan are designed to accurately and rapidly identify and quantify more than 1,100 proteins across seven logs of concentration in small sample volumes. SomaLogic’s competitive advantage lays in the breadth and depth of coverage its devices offer in biomarker discovery, diagnostics development, and pharmaceutical discovery and development. SomaLogic’s products have applications in the… Continue Reading →
$99 Single Company AccessInstant Full Site-Wide Access|
Get Full Access To This Report
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
PrivCo is the authority for financial & business data on major private companies, including:
| Private Companies | 209,371 |
| Private Investors | 12,087 |
| Private M&A Deals | 43,291 |
| VC/Funding Rounds | 36,227 |
| Total Data Points | 95,786,176 |
You are viewing a free limited preview of SomaLogic, Inc.
PrivCo is the premier source for business and financial data on major, non-publicly traded corporations, including family owned, private equity owned, venture backed, and international unlisted companies. Click here to learn more.
PDF VERSION: Download Company Report in PDF Format
Full Online Report